欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号DE/H/0929/001
药品名称OsvaRen
活性成分
    • calcium acetate 435.0 mg
    • MAGNESIUM CARBONATE, HEAVY 235.0 mg
剂型Film-coated tablet
上市许可持有人Fresenius Medical Care Nephrologica Deutschland GmbH Else-Kröner-Str. 1 61352 Bad Homburg v.d.H. Germany
参考成员国 - 产品名称Germany (DE)
互认成员国 - 产品名称
    • Belgium (BE)
    • Netherlands (NL)
    • United Kingdom (Northern Ireland) (XI)
    • Austria (AT)
      OsvaRen 435 mg / 235 mg Filmtabletten
    • France (FR)
    • Spain (ES)
    • Portugal (PT)
    • Italy (IT)
    • Lithuania (LT)
      OsvaRen 435 mg/ 235 mg plėvele dengtos tabletės
    • Czechia (CZ)
      Osvaren
    • Slovakia (SK)
    • Romania (RO)
      OsvaRen 435 mg/235 mg comprimate filmate
许可日期2007/08/08
最近更新日期2023/02/22
药物ATC编码
    • V03AE04 calcium acetate and magnesium carbonate
申请类型
  • TypeLevel1：Known Active Substance
  • TypeLevel2：Multiple (Copy) Application
  • TypeLevel3：Bibliographic Art 10 a Dir 2001/83/EC
  • TypeLevel4：Chemical Substance
  • TypeLevel5：Non Prescription (including OTC)
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase